Orthofix Medical (OFIX) Scheduled to Post Earnings on Thursday

Orthofix Medical (NASDAQ:OFIX) will be posting its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Orthofix Medical to post earnings of ($0.14) per share for the quarter. Orthofix Medical has set its FY 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Orthofix Medical (NASDAQ:OFIX) last announced its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). The firm had revenue of $198.62 million during the quarter, compared to the consensus estimate of $195.75 million. Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. On average, analysts expect Orthofix Medical to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Orthofix Medical Stock Down 0.1 %

Shares of Orthofix Medical stock opened at $16.35 on Thursday. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. The firm has a market cap of $624.16 million, a P/E ratio of -5.13 and a beta of 1.05. Orthofix Medical has a fifty-two week low of $9.57 and a fifty-two week high of $17.67. The business has a 50-day moving average price of $16.17 and a 200 day moving average price of $15.05.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.